Ticker Details
Xeris Pharmaceuticals, Inc.
IPO Date:	June 22, 2018
Sector:	Healthcare
Market Cap:	$1.59B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 3.66%
Avg Daily Range (30 D):	$0.19 | 2.24%
Avg Daily Range (90 D):	$0.17 | 2.39%

Institutional Daily Volume
Avg Daily Volume:	1.49M
Avg Daily Volume (30 D):	1.34M
Avg Daily Volume (90 D):	1.46M

Trade Size
Avg Trade Size (Sh.):	197
Avg Trade Size (Sh.) (30 D):	81
Avg Trade Size (Sh.) (90 D):	95

Institutional Trades
Total Institutional Trades:	690
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$2.01M
Avg Institutional Trade (90 D):	$1.92M
Avg Institutional Trade Volume:	.32M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.91M
Avg Closing Trade (30 D):	$2.07M
Avg Closing Trade (90 D):	$2.07M
Avg Closing Volume:	322.12K

News

Aug 7, 2025 @ 3:55 PM Xeris (XERS) Q2 Revenue Jumps 49% Source: Jesterai

May 9, 2024 @ 12:10 PM Xeris Biopharma (XERS) Reports Q1 Loss, Lags Reven... Source: Zacks Equity Research

Apr 17, 2024 @ 11:24 AM Strength Seen in MediWound (MDWD): Can Its 14.3% J... Source: Zacks Equity Research

Mar 30, 2024 @ 5:28 AM Xeris Biopharma: Checking-In On One Of My 'Top Ide... Source: Biologics

Mar 5, 2024 @ 2:42 PM Why Xeris (XERS) Might Surprise This Earnings Seas... Source: Zacks Equity Research

Financials
	TTM	Q2 2026	Q4 2026
Basic EPS	$-.1	$-.18	$.01
Diluted EPS	$-.1	$-.18	$.01
Revenue	$335.41M	$92.1M	$83.13M
Gross Profit
Net Income / Loss	$-17.17M	$-31.1M	$2.23M
Operating Income / Loss	$36.59M	$5.17M	$7.92M
Cost of Revenue
Net Cash Flow	$62.36M	$10M	$.71M
PE Ratio